Filing metadata

Accession number
0001209191-21-031474
Form type
Form 3
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
May 11, 2021
Reporting period
May 03, 2021
Description
Initial ownership

Explore SEC Filings Hub